Literature DB >> 3698824

Cefoperazone-induced coagulopathy.

H R Freedy, A B Cetnarowski, R M Lumish, F J Schafer.   

Abstract

A number of recent articles have reviewed the problem of hypoprothrombinemia and bleeding associated with antibiotic therapy. We report three cases in which bleeding is believed to be related to a prolonged prothrombin time secondary to cefoperazone therapy. Reports of coagulopathies such as these are increasing in number and call attention to the need to monitor the prothrombin time during cefoperazone therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698824     DOI: 10.1177/106002808602000413

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  5 in total

1.  Severe INR elevation in a patient with choledocholithiasis receiving cefoperazone.

Authors:  Hakan Alagozlu; Mehmet Cindoruk; Selahattin Unal
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia.

Authors:  S S Kline; V F Mauro; R B Forney; E H Freimer; P Somani
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.

Authors:  ZhuYing Cai; Wei Yang; YingYing He; Qingge Chen; ShiQiang Wang; Xuming Luo; Xiongbiao Wang
Journal:  Drug Saf Case Rep       Date:  2016-12

4.  Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report.

Authors:  Huan-Rong Hu
Journal:  Drug Saf Case Rep       Date:  2019-06-14

5.  Neglected vitamin K deficiency causing coagulation dysfunction in an older patient with pneumonia: a case report.

Authors:  Qiaoping Wu; Lufeng Wang; Rongqing Zhao
Journal:  BMC Geriatr       Date:  2022-07-30       Impact factor: 4.070

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.